Primary Site >> Liver Cancer
Gene >> PCDH9
| 1. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2014 Sep 26;452(3):567-74. | ||||||||||
| Title: | Protocadherin 9 inhibits epithelial-mesenchymal transition and cell migration through activating GSK-3beta in hepatocellular carcinoma. | ||||||||||
| Author: | Zhu, Pengfei|Lv, Jun|Yang, Ziwei|Guo, Limei|Zhang, Ling|Li, Meng|Han, Wenling|Chen, Xiangmei|Zhuang, Hui|Lu, Fengmin | ||||||||||
| PMID: | 25172662 | ||||||||||
| 2. | |||||||||||
| Journal: | Oncol Lett. 2016 Jan;11(1):624-632. | ||||||||||
| Title: | Nine susceptibility loci for hepatitis B virus-related hepatocellular carcinoma identified by a pilot two-stage genome-wide association study. | ||||||||||
| Author: | Qu, Li-Shuai|Jin, Fei|Guo, Yan-Mei|Liu, Tao-Tao|Xue, Ru-Yi|Huang, Xiao-Wu|Xu, Min|Chen, Tao-Yang|Ni, Zheng-Ping|Shen, Xi-Zhong | ||||||||||
| PMID: | 26870257 | ||||||||||
| 3. | |||||||||||
| Journal: | Mol Med Rep. 2017 Oct;16(4):4475-4482. | ||||||||||
| Title: | PCDH9 acts as a tumor suppressor inducing tumor cell arrest at G0/G1 phase and is frequently methylated in hepatocellular carcinoma. | ||||||||||
| Author: | Lv, Jun|Zhu, Pengfei|Zhang, Xiaolei|Zhang, Ling|Chen, Xiangmei|Lu, Fengmin|Yu, Zujiang|Liu, Shuang | ||||||||||
| PMID: | 28791409 | ||||||||||
| 4. | |||||||||||
| Journal: | EBioMedicine. 2018 Jul;33:57-67. | ||||||||||
| Title: | Lnc-PCDH9-13:1 Is a Hypersensitive and Specific Biomarker for Early Hepatocellular Carcinoma. | ||||||||||
| Author: | Xie, Zijun|Zhou, Fangyuan|Yang, Yidong|Li, Leijia|Lei, Yiming|Lin, Xianyi|Li, Haijiao|Pan, Xuemei|Chen, Jianning|Wang, Genshu|Liu, Huiling|Jiang, Jie|Wu, Bin | ||||||||||
| PMID: | 30045829 | ||||||||||